In a nutshell This study investigated the effectiveness and safety of Collagenase Clostridium histolyticum (CCH) in the treatment of acute phase Peyronie’s disease (PD). Researchers suggested that CCH therapy improves the outcomes of these patients. Some background PD consists of the formation of scar tissue inside the penis. It affects...
Read MoreErectile dysfunction Posts on Medivizor
Alternative treatments for erectile dysfunction: A review
In a nutshell This study reviewed several different treatments for erectile dysfunction (ED). Researchers suggested that alternative treatments combined with phosphodiesterase 5 inhibitors (PDE5i) are associated with improved effectiveness. Some background ED is one of the most frequent sexual health conditions. It affects around 18 million...
Read MoreWhat are the effects of surgical treatments after Clostridium histolyticum failure in Peyronie’s disease?
In a nutshell This study investigated the effects of surgery in patients with Peyronie's disease previously treated with Collagenase Clostridium histolyticum (CCH; Xiaflex). The main finding was that surgical treatments may improve persistent penis curvature (PC) in these patients. Some background Peyronie's disease is caused by the...
Read MoreLow-intensity extracorporeal shockwave therapy is an effective and safe treatment for erectile dysfunction
In a nutshell This study investigated if low-intensity extracorporeal shockwave therapy (LIEST) is a good treatment for patients with erectile dysfunction (ED). Researchers suggested that LIEST is a good and safe treatment for these patients. Some background ED consists of the inability to get and keep an erection firm enough for sex. This...
Read MoreTriglyceride-glucose index is a helpful factor for the diagnosis and follow-up of erectile dysfunction
In a nutshell This study investigated if the triglyceride-glucose index (TGI) is associated with erectile dysfunction (ED). Researchers suggested that TGI is a useful factor in the diagnosis and follow-up of ED. Some background ED consists of the inability to get and keep an erection firm enough for sex. Some of the risk factors for this...
Read MoreWhat are the treatment options for Peyronie’s disease?
In a nutshell This review looked at the varying treatments for Peyronie’s disease (PD) and their effectiveness in treating it. Some background PD is a condition resulting from fibrous scar tissue that develops on the penis and causes curved, painful erections. This condition becomes more common with age. Sexual function can be...
Read MoreEvaluating a drink supplement to improve male sexual function in men taking PDE5-inhibitors
In a nutshell This study investigated the effectiveness of a drink supplement with testofen, L-citrulline, resveratrol, and caffeine (TLRC) in improving sexual function in men taking phosphodiesterase type 5 inhibitors (PDE5-i). Researchers suggested that the TLRC drink improves the sexual function in these patients. Some background Erectile...
Read MoreRestoreX improves the sexual function of patients with Peyronie’s disease
In a nutshell This study reported the extended follow-up outcomes on RestoreX effectiveness in men with Peyronie´s disease (PD). Researchers suggested that RestoreX improves the length, curve, and sexual function of these patients. Some background PD is caused by the formation of scar tissue inside the penis. This can result in a bent erect...
Read MorePlaque incision or excision and grafting of collagen TachoSil improves the outcomes of patients with Peyronie’s disease
In a nutshell This study investigated the effectiveness and safety of plaque incision/excision and or grafting (PIG/PEG) with collagen TachoSil to treat erectile dysfunction in patients with Peyronie's disease (PD). Researchers suggested that PIG/PEG is a good and safe procedure to treat these patients. Some background PD consists of...
Read MoreEvaluating intralesional methylprednisolone injections for active phase Peyronie’s disease.
In a nutshell This study was carried out to assess the effectiveness of methylprednisolone (MP; Medrol) injections in treating the active phase of Peyronie’s disease (PD). The authors concluded that low dose MP for active phase PD is a promising and safe treatment option. Some background PD is...
Read MoreShock-wave treatment for erectile dysfunction in patients unresponsive to PDE5I therapy
In a nutshell This trial was carried out to assess the effectiveness of low-intensity extracorporeal shockwave therapy (LI-ESWT) for the treatment of patients with erectile dysfunction (ED) who do not respond to vascular medications such as phosphodiesterase type 5 inhibitors (PDE5Is). The authors found that LI-ESWT may improve erectile function in these...
Read MoreIntracavernosal injection of prostaglandin E1 in erectile dysfunction – does the dose matter?
In a nutshell This study investigated the effectiveness of different doses of prostaglandin E1 (PGE1) penis injection in patients with erectile dysfunction (ED) caused by blood vessel problems. Researchers suggested that PGE1 injections with increasing doses improved the rigidity and duration or erection in patients with different types of ED. Some...
Read More